Literature DB >> 10576403

Clinical equivalence.

D R Bristol1.   

Abstract

When the classical approach of testing the null hypothesis of equality is used and the results are not statistically significant, formal conclusions regarding the "closeness" of the treatments cannot be drawn. When the purpose of the investigation is to exhibit "closeness," misinterpretations may result in inappropriate, or even incorrect, conclusions. Here methodology for use when the goal is to exhibit the equivalence (noninferiority) of the treatments is discussed. The techniques allow direct conclusions to be drawn regarding the equivalence of the treatments. A review is presented.

Mesh:

Year:  1999        PMID: 10576403     DOI: 10.1081/bip-100101195

Source DB:  PubMed          Journal:  J Biopharm Stat        ISSN: 1054-3406            Impact factor:   1.051


  6 in total

1.  What have we learned about trial design from NIMH-funded pragmatic trials?

Authors:  John March; Helena C Kraemer; Madhukar Trivedi; John Csernansky; John Davis; Terence A Ketter; Ira D Glick
Journal:  Neuropsychopharmacology       Date:  2010-08-25       Impact factor: 7.853

2.  Rapid subcutaneous IgG replacement therapy is effective and safe in children and adults with primary immunodeficiencies--a prospective, multi-national study.

Authors:  Ann Gardulf; Uwe Nicolay; Oscar Asensio; Ewa Bernatowska; Andreas Böck; Beatriz Costa Carvalho; Carl Granert; Stefan Haag; Dolores Hernández; Peter Kiessling; Jan Kus; Jaune Pons; Tim Niehues; Sigune Schmidt; Ilka Schulze; Michael Borte
Journal:  J Clin Immunol       Date:  2006-04-26       Impact factor: 8.317

3.  Randomised equivalency trial comparing 2.5% povidone-iodine eye drops and ophthalmic chloramphenicol for preventing neonatal conjunctivitis in a trachoma endemic area in southern Mexico.

Authors:  Marco A Ramirez-Ortiz; Manuel Rodriguez-Almaraz; Héctor Ochoa-Diazlopez; Paulina Diaz-Prieto; Romeo S Rodriguez-Suárez
Journal:  Br J Ophthalmol       Date:  2007-11       Impact factor: 4.638

4.  Methadone patients in the therapeutic community: a test of equivalency.

Authors:  James L Sorensen; Siara Andrews; Kevin L Delucchi; Brian Greenberg; Joseph Guydish; Carmen L Masson; Michael Shopshire
Journal:  Drug Alcohol Depend       Date:  2008-11-14       Impact factor: 4.492

5.  Bioequivalence testing by statistical shape analysis.

Authors:  Luis Marcelo Pereira
Journal:  J Pharmacokinet Pharmacodyn       Date:  2007-06-07       Impact factor: 2.410

6.  Maternal anaemia and duration of zidovudine in antiretroviral regimens for preventing mother-to-child transmission: a randomized trial in three African countries.

Authors:  Benn K D Sartorius; Matthew F Chersich; Mary Mwaura; Nicolas Meda; Marleen Temmerman; Marie Louise Newell; Timothy M M Farley; Stanley Luchters
Journal:  BMC Infect Dis       Date:  2013-11-06       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.